Audientes A/S: Q3 2025 Financial Report
Audientes A/S ("Audientes" or the "Company"), CVR 36047631, announces its unaudited financial results for Q3 2025. The Company provides updates on progress in its key markets and on product development.
Company announcement no. 15-2025
November 30, 2025
Operating Highlights
- Significant Product Order confirmed; delivery and revenue recognition awaiting customer readiness: Audientes received the formal purchase order of approx. DKK 0.8 million and invoiced its strategic partner SimplyJITH Traders Middle East. Delivery and payment are awaiting customer's readiness, and therefore no revenue related to this order was recognised in Q3. Revenue recognition is now expected once delivery can be completed, likely in Q4.
- China regulatory progress and product localization: The NMPA submission work for the updated Chinese Ven™ hearing aid continued in Q3 via our joint venture ZhiYinYou Technology Ltd. All core documentation is prepared and submitted, with approval expected within the next six months. Localization of the Companion-based "ZhiYinYou" hearable device also advanced, with products prepared and app finalization ongoing.
- Middle East and Africa (MEA) market development: Our Turkish partner Audivista continued to advance market preparations, including engagement with public-sector channels and specialty retail. Similarly in South Africa, where we have entered the market with a new partner, Audiseven, and obtained local telecomms approval from the regulator ICASA.
- E-commerce in Europe and Japan: Companion remains available on Amazon UK via our partner RMX Digital, with rollout to additional European storefronts is ongoing with local market approval efforts (including EPR in the EU) and will be accelerated once marketing funding is secured. In Japan, our dedicated e-commerce campaign site is live, and further promotional and operational activities will be launched as soon as resources permit further investment in GTM.
Financial highlights
| TDKK | Q3 2025 | Q3 2024 | Q1-Q3 2025 | Q1-Q3 2024 | 2024 |
| Revenue | 42 | 63 | 126 | 90 | 630 |
| Other operating income | 214 | 214 | 655 | 642 | 1,068 |
| EBITDA | -888 | -901 | -4,015 | -3,930 | -5,379 |
| Profit/loss for the period | -2,284 | -2,513 | -8,577 | -8,253 | -10,733 |
| Cash and cash equivalents | 86 | 8 | 86 | 8 | 9 |
| Equity | -3,313 | 1,284 | -3,313 | 1,284 | 1,199 |
| Equity ratio (%) | -63.9% | 13.1% | -63.9% | 13.1% | 13.6% |
| Earnings per share (DKK) | -0.00 | -0.01 | -0.02 | -0.06 | -0.05 |
| No. of shares beginning of the period | 678,551,252 | 200,392,676 | 399,411,640 | 59,384,318 | 59,384,318 |
| No. of shares end of period | 678,551,252 | 200,392,676 | 678,551,252 | 200,392,676 | 399,411,640 |
| Average number of shares | 678,551,252 | 200,392,676 | 538,981,446 | 129,888,497 | 229,397,979 |
In April 2024, the nominal value per share was reduced from DKK 0.10 to DKK 0.01. At the same time, the nominal share capital was reduced by DKK 6,244,589, corresponding to 624,458,900 shares, each with a nominal value of DKK 0.01.
- Revenue performance: Revenue for Q3 2025 amounted to TDKK 42 (Q3 2024: TDKK 63). For the first nine months of 2025 (Q1-Q3), revenue totalled TDKK 126 (Q1-Q3 2024: TDKK 90).
- EBITDA: EBITDA for Q3 2025 was TDKK -888 (Q3 2024: TDKK -901). For Q1-Q3 2025, EBITDA totalled TDKK -4,015 (TDKK -3,930 in Q1-Q3 2024).
- Profit/loss for the period: The net result for Q3 2025 was TDKK -2,284 (Q3 2024: TDKK -2,513) and TDKK -8,577 for Q1-Q3 2025 (TDKK -8,253 in Q1-Q3 2024).
- Cash position: Cash and cash equivalents at the end of Q3 2025 amounted to TDKK 86 (end of 2024: TDKK 9).
- Negative equity: Equity as of 30 September 2025 was TDKK -3,313, corresponding to an equity ratio of -63.9%. More than 50% of the share capital has been lost, however, the Management feel confident that the share capital will be reestablished by both funding events and future profit.
- Financing strategy: The previously planned corporate bond of up to DKK 15 million (EUR 2 million) on the Bulgarian BEAM market will not be pursued further. Given the company's financial position and changes within the advisory team, this route is no longer viable. The company is now focusing on alternative financing and strategic partnership solutions to drive product sales.
For further information, please contact:
Steen Thygesen, CEO, Audientes A/S
Phone: +45 77 34 16 80
Email: st@audientes.com
About Audientes A/S
Audientes A/S is a Danish hearing technology company specializing in smart, self-fitting and affordable hearing aids, hearables, and hearing protection solutions. Our mission is to make high-quality hearing technology accessible to everyone - whether for hearing improvement, enhancement, or protection - across consumer, medical, and industrial sectors worldwide.
In addition to our own products, we are developing a licensing business based on our proprietary software and hearing technology platform. This allows third-party brands, OEMs, and manufacturers to integrate our proven self-fitting and audio-processing capabilities into their own hearing products and solutions, thereby expanding our global reach and revenue potential.
Audientes is listed on Spotlight Stock Market Denmark (AUDNTS) and headquartered in Copenhagen, Denmark, with subsidiaries in Hyderabad, India, and in Tokyo, Japan. Audientes also holds a 40% stake in a joint venture, ZhiYinYou Technology Limited, with Shenzhen Hengtong Partner Co. Ltd. in China.
For more information, please visit our websites www.audientes.com, www.audientes.eu, www.audientes.co.jp, www.audientes.in, or follow us on our social media channels.